In conclusion, we first demonstrated that a novel combination treatment regimen consisting of curcumin and andrographis exhibited anti-tumorigenic effects in CRC through ferroptosis caused by dual suppression of GPX-4 and FSP-1. The gene discussed is AIFM2; the disease is colorectal carcinoma.